Valion Bio (VBIO) EBT Margin Growth (1y) (2022 - 2026)
Valion Bio (VBIO) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 546.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4,709.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1,076.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1,911.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 29,565.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -392.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2,507.00 |
| 10 | Valion Bio | 420,133.64 | -1.78 Mn | -45,000.00 | 213,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.78 Mn |
| Dec 31, 2025 | 93,014.00 |
| Sep 30, 2025 | -56,223.00 |
| Jun 30, 2025 | -130,169.00 |
| Mar 31, 2025 | -169,275.00 |
| Dec 31, 2024 | -19,575.00 |
| Sep 30, 2024 | -49,352.00 |
| Jun 30, 2024 | 40,503.00 |
| Mar 31, 2024 | 11,738.00 |
| Dec 31, 2023 | -7,770.00 |
| Sep 30, 2023 | -9,000.00 |
| Jun 30, 2023 | -77,111.00 |
| Mar 31, 2023 | 2,230.00 |
| Dec 31, 2022 | 2,376.00 |
| Sep 30, 2022 | -10,852.00 |
| Jun 30, 2022 | -10,419.00 |
| Mar 31, 2022 | -17,855.00 |